3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Stomatitis
1
Mucositis
1
Mouth Neoplasms
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
6
Cisplatin
6
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiotherapy
3
Radiation
3
Nivolumab
3
Fluorouracil
3
Biopsy
3
Surveys and Questionnaires
2
Radiosurgery
2
Paclitaxel
2
Chemoradiotherapy
2
Cetuximab
2
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
2
zimberelimab
1
toripalimab
1
temsirolimus
1
peposertib
1
nabiximols
1
motexafin gadolinium
1
mogamulizumab
1
ipatasertib
1
dl1520
1
camrelizumab
1
brodalumab
1
belinostat
1
apatinib
1
advexin
1
Valproic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Mouth Neoplasms
×
Traumeel S
×
Clear all
NCT00584597
2010-12-13
TRAUMEEL
University of Oklahoma
Phase 1
Completed
14 enrolled